VERACYTE, INC. (VCYT) Operating Margin
- Operating margin · 12 months: Value 18.82%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 18.82% | Operating income / revenue. Period ending 2026-06-30. $105.77M ÷ $561.90M × 100 ≈ 18.82% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 105.77M USD | Operating Income (Loss) |
| Revenue | 561.90M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | (m) | |
| Research and development | 93.37M USD | Research and Development Expense |
| Selling, general and administration | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105.77M | $561.90M | (m) | $93.37M | (m) | 18.82% |
| 2026-03-31 | $77.52M | $541.74M | (m) | $80.19M | (m) | 14.31% |
| 2025-12-31 | $57.78M | $517.14M | (m) | $70.81M | (m) | 11.17% |
| 2025-09-30 | $24.76M | $495.14M | (m) | $69.25M | (m) | 5.00% |
| 2025-06-30 | $13.83M | $479.13M | (m) | $70.85M | (m) | 2.89% |
| 2025-03-31 | $23.70M | $463.39M | (m) | $71.05M | (m) | 5.11% |
| 2024-12-31 | $16.14M | $445.76M | (m) | $69.29M | (m) | 3.62% |
| 2024-09-30 | $-23.54M | $425.33M | (m) | $68.68M | (m) | -5.53% |
| 2024-06-30 | $-67.30M | $399.58M | (m) | $64.42M | (m) | -16.84% |
| 2024-03-31 | $-79.95M | $375.47M | (m) | $60.50M | (m) | -21.29% |
| 2023-12-31 | $-85.80M | $361.05M | (m) | $57.30M | (m) | -23.76% |
| 2023-09-30 | $-55.71M | $343.15M | (m) | $49.92M | (m) | -16.23% |
| 2023-06-30 | $-33.65M | $328.63M | (m) | $47.37M | (m) | -10.24% |
| 2023-03-31 | $-36.33M | $311.18M | (m) | $44.21M | (m) | -11.68% |
| 2022-12-31 | $-41.08M | $296.54M | (m) | $40.60M | (m) | -13.85% |
| 2022-09-30 | $-47.99M | $283.57M | (m) | $39.57M | (m) | -16.92% |
| 2022-06-30 | $-54.99M | $268.35M | (m) | $36.80M | (m) | -20.49% |
| 2022-03-31 | $-51.74M | $250.59M | (m) | $33.67M | (m) | -20.65% |
| 2021-12-31 | $-81.90M | $219.51M | (m) | $29.84M | (m) | -37.31% |
| 2021-09-30 | $-77.64M | $186.71M | (m) | $24.18M | (m) | -41.58% |
| 2021-06-30 | $-65.03M | $157.47M | (m) | $20.21M | (m) | -41.30% |
| 2021-03-31 | $-68.60M | $123.06M | (m) | $18.13M | (m) | -55.75% |
| 2020-12-31 | $-35.39M | $117.48M | (m) | $17.20M | (m) | -30.12% |
| 2020-09-30 | $-35.51M | $112.68M | (m) | $17.06M | (m) | -31.52% |
| 2020-06-30 | $-33.21M | $112.53M | (m) | $16.66M | (m) | -29.51% |
| 2020-03-31 | $-25.26M | $121.96M | (m) | $15.82M | (m) | -20.71% |
| 2019-12-31 | $-15.13M | $120.37M | (m) | $14.85M | (m) | -12.57% |
| 2019-09-30 | $-9.99M | $116.39M | (m) | $13.53M | (m) | -8.58% |
| 2019-06-30 | $-12.53M | $108.88M | (m) | $13.31M | (m) | -11.51% |
| 2019-03-31 | $-15.35M | $101.50M | (m) | $14.58M | (m) | -15.12% |
| 2018-12-31 | $-22.23M | $92.01M | (m) | $14.82M | (m) | -24.16% |
| 2018-09-30 | $-25.22M | $85.85M | (m) | $14.90M | (m) | -29.38% |
| 2018-06-30 | $-27.28M | $79.91M | (m) | $14.52M | (m) | -34.14% |
| 2018-03-31 | $-27.98M | $75.56M | (m) | $13.53M | (m) | -37.02% |
| 2017-12-31 | $-26.54M | $71.95M | (m) | $13.88M | (m) | -36.88% |
| 2017-09-30 | $-24.17M | $70.61M | (m) | $14.27M | (m) | -34.22% |
| 2017-06-30 | $-22.68M | $71.70M | (m) | $15.23M | (m) | -31.64% |
| 2017-03-31 | $-26.57M | $67.97M | (m) | $15.89M | (m) | -39.09% |
| 2016-12-31 | $-28.80M | $65.08M | (m) | $15.32M | (m) | -44.25% |
| 2016-09-30 | $-33.08M | $60.87M | (m) | $15.08M | (m) | -54.35% |
| 2016-06-30 | $-37.08M | $54.60M | (m) | $14.63M | (m) | -67.92% |
| 2016-03-31 | $-35.66M | $51.84M | (m) | $13.47M | (m) | -68.80% |
| 2015-12-31 | $-33.47M | $49.50M | (m) | $12.80M | (m) | -67.60% |
| 2015-09-30 | $-33.57M | $47.66M | (m) | $12.65M | (m) | -70.44% |
| 2015-06-30 | $-32.50M | $45.16M | (m) | $11.32M | (m) | -71.95% |
| 2015-03-31 | $-29.98M | $41.93M | (m) | $10.46M | (m) | -71.51% |
| 2014-12-31 | $-29.01M | $38.19M | (m) | $9.80M | (m) | -75.95% |
| 2014-09-30 | $-26.71M | $32.83M | (m) | $8.47M | (m) | -81.36% |
| 2014-06-30 | $-25.00M | $28.59M | (m) | $8.27M | (m) | -87.45% |
| 2014-03-31 | $-23.86M | $24.98M | (m) | $7.93M | (m) | -95.51% |
| 2013-12-31 | $-23.17M | $21.88M | (m) | $7.81M | (m) | -105.89% |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | $17.13M | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | $14.54M | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-18.93M | $11.63M | (m) | $6.61M | (m) | -162.79% |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $-15.27M | $2.65M | (m) | $6.68M | (m) | -577.16% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |